Effects of obesity on response to asthma biologic treatment: Longitudinal data from the United Kingdom Severe Asthma Registry肥胖对哮喘生物制剂治疗反应的影响:来自英国重症哮喘登记研究的纵向数据The Journal of Allergy and Clinical Immunology: In PracticeIF02025-08-050OAAI
Health-related quality of life (HRQoL) in depression defined by clinicians and patients in severe asthma. Data from SHARP CRCEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Health-related quality of life and asthma control in patients receiving or not receiving biologic treatments for severe asthma. Data from SHARP CRCEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
The patient health-related quality of life (HRQoL) burden of severe asthma in Europe (SHARP CRC) for specific subgroupsEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Relationship between the Severe Asthma Questionnaire and the EQ-5D-5L for health- related quality of life in the SHARP CRC registryEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Patients' knowledge, perspectives and attitudes towards treatment goals and clinical remission in severe asthmaEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Body Reprogramming for the extra-pulmonary symptoms of severe asthmaEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Moving towards patient-centred outcomes: the Severe Asthma QuestionnaireEUROPEAN RESPIRATORY JOURNALIF212022-12-300OA
Reply to '''Nothing about us without us' - What matters to patients with severe asthma?''JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62022-03-011PRE
A questionnaire to measure the extra-pulmonary symptoms of asthmaEUROPEAN RESPIRATORY JOURNALIF212021-11-250OA
Derivation and validation of the subscales of the severe asthma questionnaireEUROPEAN RESPIRATORY JOURNALIF212021-11-250PRE
The Severe Asthma Questionnaire (SAQ) - minimal clinically important difference and sensitivity to changeEUROPEAN RESPIRATORY JOURNALIF212021-11-250PRE
Defining a Severe Asthma Super-Responder: Findings from a Delphi ProcessJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62021-11-01104OAAI
Comparison of the sensitivity of patient-reported outcomes for detecting the benefit of biologics in severe asthma比较患者报告的结果对检测生物制剂在重症哮喘中的益处的敏感性CHRONIC RESPIRATORY DISEASEIF2.32021-09-2511OAAI
The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important differenceEUROPEAN RESPIRATORY JOURNALIF212021-02-258OAAI
Quality of life in severe asthma measured by SAQ and EQ5D questionnaires as a function of clinically relevant cut off pointsEUROPEAN RESPIRATORY JOURNALIF212020-10-281PRE
Is the minimally clinically important difference (MCID) fit for purpose? A planned study using the SAQEUROPEAN RESPIRATORY JOURNALIF212020-10-282PRE
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi processEUROPEAN RESPIRATORY JOURNALIF212020-10-283PRE
The SAQ is a valid quality of life measure in severe asthma: the mini-AQLQ and ACQ both measure symptomsEUROPEAN RESPIRATORY JOURNALIF212020-10-280PRE
Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA)HEALTH AND QUALITY OF LIFE OUTCOMESIF3.42020-10-0917OAAI